Save the date! The 2026 New England Hematologic Diseases Symposium will be held on Friday, November 6.
New England Hematologic Diseases Symposium
Our goal is to share best practices and to discuss complex scenarios with physicians, APPs and nurses in the New England region. With Drs. Syed Saqib Ali, Adam Boruchov, Amer Zeidan, and Sudhanshu Mulay as the Steering Committee, we have assembled a diverse faculty of renowned experts from around the country to discuss state-of-the-art therapy and the latest findings on the management of patients with hematologic malignancies and benign hematological diseases. Our goal is to share best practices and to discuss complex scenarios with physicians, APPs and nurses in the New England region. We encourage residents and fellows as well as pharmacists, research staff and other healthcare professionals interested in the field to join us.
Scientific Steering Committee
-

Adam Boruchov, MD
Physician-in-Chief, Hartford HealthCare Cancer Institute
Event Co-Chair -

Amer Zeidan, MBBS, MHS
Smilow Cancer Hospital, Yale Cancer Center
Event Co-Chair -

Sudhanshu B. Mulay, MD, MBBS
Director, Anticoagulation Program, Classical Hematology Program
Yale School of Medicine -

Syed Saqib Ali, MBBS, MD
Hematology Director
Trinity Health/ Yale Smilow Cancer Center at Saint Francis
Speakers & Topics
Hanny Al-Samkari, MD
How I Treat Chemotherapy-Induced Thrombocytopenia
Mass General Brigham Cancer Institute, Massachusetts General Hospital, Harvard Medical School
Jennifer R. Brown, MD, PhD
Updates on Chronic Lymphocytic Leukemia
Dana-Farber Cancer Institute
Adam Cuker, MD, MS
How I Treat Refractory Immune Thrombocytopenia
Perelman School of Medicine, University of Pennsylvania
James D. Douketis, MD, FRCP(C), FCAHS
How I Manage Preoperative Anticoagulation
McMaster University
Amy E. DeZern, MD, MHS
How I Manage Myelodysplastic Syndrome and Aplastic Anemia in 2026
Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University
Andrew M. Evens, DO, MBA, MSc
Updates on Diffuse Large B-cell Lymphoma
Rutgers Cancer Institute of New Jersey
Ruben A. Mesa, MD
Pivoting to Targeted MPN Therapy
Atrium Health Wake Forest Baptist Comprehensive Cancer Center
Muzaffar Qazilbash, MD
When and How to Sequence CAR in Relapse Myeloma > CURE?
MD Anderson Cancer Center
Joshua Richter, MD, FACP
Myeloma: What to Do If It Relapses
The Tisch Cancer Institute, Mount Sinai
Saad Z. Usmani, MD, MBA, FASCO
Smoldering and Newly Diagnosed Myeloma
Memorial Sloan Kettering Cancer Center
Amer Zeidan, MBBS, MHS
Updates on Management of Acute Myeloid Leukemia
Smilow Cancer Hospital, Yale Cancer Center
Venue
Bristol Event Center
112 Century Drive Bristol, CT 06010